Animal Antimicrobials and Antibiotics-North America Market Status and Trend Report 2013-2023
Report Summary
Animal Antimicrobials and Antibiotics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Antimicrobials and Antibiotics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Animal Antimicrobials and Antibiotics 2013-2017, and development forecast 2018-2023
Main market players of Animal Antimicrobials and Antibiotics in North America, with company and product introduction, position in the Animal Antimicrobials and Antibiotics market
Market status and development trend of Animal Antimicrobials and Antibiotics by types and applications
Cost and profit status of Animal Antimicrobials and Antibiotics, and marketing status
Market growth drivers and challenges
The report segments the North America Animal Antimicrobials and Antibiotics market as:
North America Animal Antimicrobials and Antibiotics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Animal Antimicrobials and Antibiotics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Tetracyclines
Penicillins
Sulfonamides
Macrolides
Aminoglycosides
Lincosamides
Fluoroquinolones
Cephalosporins
Others
North America Animal Antimicrobials and Antibiotics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Food-Producing Animals
Companion Animals
North America Animal Antimicrobials and Antibiotics Market: Players Segment Analysis (Company and Product introduction, Animal Antimicrobials and Antibiotics Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Eli Lilly and Company
Merck & Co.
Bayer
Sanofi
Ceva Sante Animale
Virbac
Vetoquinol
Dechra Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Animal Antimicrobials and Antibiotics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Antimicrobials and Antibiotics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole North America and Regional Market Size of Animal Antimicrobials and Antibiotics 2013-2017, and development forecast 2018-2023
Main market players of Animal Antimicrobials and Antibiotics in North America, with company and product introduction, position in the Animal Antimicrobials and Antibiotics market
Market status and development trend of Animal Antimicrobials and Antibiotics by types and applications
Cost and profit status of Animal Antimicrobials and Antibiotics, and marketing status
Market growth drivers and challenges
The report segments the North America Animal Antimicrobials and Antibiotics market as:
North America Animal Antimicrobials and Antibiotics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico
North America Animal Antimicrobials and Antibiotics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Tetracyclines
Penicillins
Sulfonamides
Macrolides
Aminoglycosides
Lincosamides
Fluoroquinolones
Cephalosporins
Others
North America Animal Antimicrobials and Antibiotics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Food-Producing Animals
Companion Animals
North America Animal Antimicrobials and Antibiotics Market: Players Segment Analysis (Company and Product introduction, Animal Antimicrobials and Antibiotics Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Eli Lilly and Company
Merck & Co.
Bayer
Sanofi
Ceva Sante Animale
Virbac
Vetoquinol
Dechra Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
1.1 Definition of Animal Antimicrobials and Antibiotics in This Report
1.2 Commercial Types of Animal Antimicrobials and Antibiotics
1.2.1 Tetracyclines
1.2.2 Penicillins
1.2.3 Sulfonamides
1.2.4 Macrolides
1.2.5 Aminoglycosides
1.2.6 Lincosamides
1.2.7 Fluoroquinolones
1.2.8 Cephalosporins
1.2.9 Others
1.3 Downstream Application of Animal Antimicrobials and Antibiotics
1.3.1 Food-Producing Animals
1.3.2 Companion Animals
1.4 Development History of Animal Antimicrobials and Antibiotics
1.5 Market Status and Trend of Animal Antimicrobials and Antibiotics 2013-2023
1.5.1 North America Animal Antimicrobials and Antibiotics Market Status and Trend 2013-2023
1.5.2 Regional Animal Antimicrobials and Antibiotics Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Antimicrobials and Antibiotics in North America 2013-2017
2.2 Consumption Market of Animal Antimicrobials and Antibiotics in North America by Regions
2.2.1 Consumption Volume of Animal Antimicrobials and Antibiotics in North America by Regions
2.2.2 Revenue of Animal Antimicrobials and Antibiotics in North America by Regions
2.3 Market Analysis of Animal Antimicrobials and Antibiotics in North America by Regions
2.3.1 Market Analysis of Animal Antimicrobials and Antibiotics in United States 2013-2017
2.3.2 Market Analysis of Animal Antimicrobials and Antibiotics in Canada 2013-2017
2.3.3 Market Analysis of Animal Antimicrobials and Antibiotics in Mexico 2013-2017
2.4 Market Development Forecast of Animal Antimicrobials and Antibiotics in North America 2018-2023
2.4.1 Market Development Forecast of Animal Antimicrobials and Antibiotics in North America 2018-2023
2.4.2 Market Development Forecast of Animal Antimicrobials and Antibiotics by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Animal Antimicrobials and Antibiotics in North America by Types
3.1.2 Revenue of Animal Antimicrobials and Antibiotics in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Animal Antimicrobials and Antibiotics in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Antimicrobials and Antibiotics in North America by Downstream Industry
4.2 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in United States
4.2.2 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in Canada
4.2.3 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in Mexico
4.3 Market Forecast of Animal Antimicrobials and Antibiotics in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
5.1 North America Economy Situation and Trend Overview
5.2 Animal Antimicrobials and Antibiotics Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Animal Antimicrobials and Antibiotics in North America by Major Players
6.2 Revenue of Animal Antimicrobials and Antibiotics in North America by Major Players
6.3 Basic Information of Animal Antimicrobials and Antibiotics by Major Players
6.3.1 Headquarters Location and Established Time of Animal Antimicrobials and Antibiotics Major Players
6.3.2 Employees and Revenue Level of Animal Antimicrobials and Antibiotics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Animal Antimicrobials and Antibiotics Product
7.1.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Boehringer Ingelheim
7.2.1 Company profile
7.2.2 Representative Animal Antimicrobials and Antibiotics Product
7.2.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.3 Eli Lilly and Company
7.3.1 Company profile
7.3.2 Representative Animal Antimicrobials and Antibiotics Product
7.3.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.4 Merck & Co.
7.4.1 Company profile
7.4.2 Representative Animal Antimicrobials and Antibiotics Product
7.4.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Bayer
7.5.1 Company profile
7.5.2 Representative Animal Antimicrobials and Antibiotics Product
7.5.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Bayer
7.6 Sanofi
7.6.1 Company profile
7.6.2 Representative Animal Antimicrobials and Antibiotics Product
7.6.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Sanofi
7.7 Ceva Sante Animale
7.7.1 Company profile
7.7.2 Representative Animal Antimicrobials and Antibiotics Product
7.7.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Antimicrobials and Antibiotics Product
7.8.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol
7.9.1 Company profile
7.9.2 Representative Animal Antimicrobials and Antibiotics Product
7.9.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Vetoquinol
7.10 Dechra Pharmaceuticals
7.10.1 Company profile
7.10.2 Representative Animal Antimicrobials and Antibiotics Product
7.10.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Dechra Pharmaceuticals
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
8.1 Industry Chain of Animal Antimicrobials and Antibiotics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
9.1 Cost Structure Analysis of Animal Antimicrobials and Antibiotics
9.2 Raw Materials Cost Analysis of Animal Antimicrobials and Antibiotics
9.3 Labor Cost Analysis of Animal Antimicrobials and Antibiotics
9.4 Manufacturing Expenses Analysis of Animal Antimicrobials and Antibiotics
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Animal Antimicrobials and Antibiotics in This Report
1.2 Commercial Types of Animal Antimicrobials and Antibiotics
1.2.1 Tetracyclines
1.2.2 Penicillins
1.2.3 Sulfonamides
1.2.4 Macrolides
1.2.5 Aminoglycosides
1.2.6 Lincosamides
1.2.7 Fluoroquinolones
1.2.8 Cephalosporins
1.2.9 Others
1.3 Downstream Application of Animal Antimicrobials and Antibiotics
1.3.1 Food-Producing Animals
1.3.2 Companion Animals
1.4 Development History of Animal Antimicrobials and Antibiotics
1.5 Market Status and Trend of Animal Antimicrobials and Antibiotics 2013-2023
1.5.1 North America Animal Antimicrobials and Antibiotics Market Status and Trend 2013-2023
1.5.2 Regional Animal Antimicrobials and Antibiotics Market Status and Trend 2013-2023
CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Antimicrobials and Antibiotics in North America 2013-2017
2.2 Consumption Market of Animal Antimicrobials and Antibiotics in North America by Regions
2.2.1 Consumption Volume of Animal Antimicrobials and Antibiotics in North America by Regions
2.2.2 Revenue of Animal Antimicrobials and Antibiotics in North America by Regions
2.3 Market Analysis of Animal Antimicrobials and Antibiotics in North America by Regions
2.3.1 Market Analysis of Animal Antimicrobials and Antibiotics in United States 2013-2017
2.3.2 Market Analysis of Animal Antimicrobials and Antibiotics in Canada 2013-2017
2.3.3 Market Analysis of Animal Antimicrobials and Antibiotics in Mexico 2013-2017
2.4 Market Development Forecast of Animal Antimicrobials and Antibiotics in North America 2018-2023
2.4.1 Market Development Forecast of Animal Antimicrobials and Antibiotics in North America 2018-2023
2.4.2 Market Development Forecast of Animal Antimicrobials and Antibiotics by Regions 2018-2023
CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole North America Market Status by Types
3.1.1 Consumption Volume of Animal Antimicrobials and Antibiotics in North America by Types
3.1.2 Revenue of Animal Antimicrobials and Antibiotics in North America by Types
3.2 North America Market Status by Types in Major Countries
3.2.1 Market Status by Types in United States
3.2.2 Market Status by Types in Canada
3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Animal Antimicrobials and Antibiotics in North America by Types
CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Antimicrobials and Antibiotics in North America by Downstream Industry
4.2 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in United States
4.2.2 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in Canada
4.2.3 Demand Volume of Animal Antimicrobials and Antibiotics by Downstream Industry in Mexico
4.3 Market Forecast of Animal Antimicrobials and Antibiotics in North America by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
5.1 North America Economy Situation and Trend Overview
5.2 Animal Antimicrobials and Antibiotics Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA
6.1 Sales Volume of Animal Antimicrobials and Antibiotics in North America by Major Players
6.2 Revenue of Animal Antimicrobials and Antibiotics in North America by Major Players
6.3 Basic Information of Animal Antimicrobials and Antibiotics by Major Players
6.3.1 Headquarters Location and Established Time of Animal Antimicrobials and Antibiotics Major Players
6.3.2 Employees and Revenue Level of Animal Antimicrobials and Antibiotics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL ANTIMICROBIALS AND ANTIBIOTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Animal Antimicrobials and Antibiotics Product
7.1.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Boehringer Ingelheim
7.2.1 Company profile
7.2.2 Representative Animal Antimicrobials and Antibiotics Product
7.2.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.3 Eli Lilly and Company
7.3.1 Company profile
7.3.2 Representative Animal Antimicrobials and Antibiotics Product
7.3.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.4 Merck & Co.
7.4.1 Company profile
7.4.2 Representative Animal Antimicrobials and Antibiotics Product
7.4.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Merck & Co.
7.5 Bayer
7.5.1 Company profile
7.5.2 Representative Animal Antimicrobials and Antibiotics Product
7.5.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Bayer
7.6 Sanofi
7.6.1 Company profile
7.6.2 Representative Animal Antimicrobials and Antibiotics Product
7.6.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Sanofi
7.7 Ceva Sante Animale
7.7.1 Company profile
7.7.2 Representative Animal Antimicrobials and Antibiotics Product
7.7.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Ceva Sante Animale
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Antimicrobials and Antibiotics Product
7.8.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol
7.9.1 Company profile
7.9.2 Representative Animal Antimicrobials and Antibiotics Product
7.9.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Vetoquinol
7.10 Dechra Pharmaceuticals
7.10.1 Company profile
7.10.2 Representative Animal Antimicrobials and Antibiotics Product
7.10.3 Animal Antimicrobials and Antibiotics Sales, Revenue, Price and Gross Margin of Dechra Pharmaceuticals
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
8.1 Industry Chain of Animal Antimicrobials and Antibiotics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
9.1 Cost Structure Analysis of Animal Antimicrobials and Antibiotics
9.2 Raw Materials Cost Analysis of Animal Antimicrobials and Antibiotics
9.3 Labor Cost Analysis of Animal Antimicrobials and Antibiotics
9.4 Manufacturing Expenses Analysis of Animal Antimicrobials and Antibiotics
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL ANTIMICROBIALS AND ANTIBIOTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
